Matches in Nanopublications for { ?s ?p "[We identified RIL, a LIM domain gene mapping to 5q31, a region frequently deleted in acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS), as methylated in 55 of 79 (70%) of cancer cell lines tested.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- NP237622.RAepdlB3tQg--BeEDRF4e5eHuUzQlmCNfEb0ym3Vhm3v4130_assertion description "[We identified RIL, a LIM domain gene mapping to 5q31, a region frequently deleted in acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS), as methylated in 55 of 79 (70%) of cancer cell lines tested.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP237622.RAepdlB3tQg--BeEDRF4e5eHuUzQlmCNfEb0ym3Vhm3v4130_provenance.
- NP929303.RAoINlHpMgSBQLY-KAV6bz_Xm195Tp_45LAO750NqD7ZM130_assertion description "[We identified RIL, a LIM domain gene mapping to 5q31, a region frequently deleted in acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS), as methylated in 55 of 79 (70%) of cancer cell lines tested.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP929303.RAoINlHpMgSBQLY-KAV6bz_Xm195Tp_45LAO750NqD7ZM130_provenance.
- NP750045.RArzbnSv_arcjb3tS-9dExLPoug0l5ix5kBeGzIAoVYnE130_assertion description "[We identified RIL, a LIM domain gene mapping to 5q31, a region frequently deleted in acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS), as methylated in 55 of 79 (70%) of cancer cell lines tested.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP750045.RArzbnSv_arcjb3tS-9dExLPoug0l5ix5kBeGzIAoVYnE130_provenance.
- NP798682.RAXHzD4PR82fpNM7XkhVbGRau0FPTJd9V6fNLCFv6QrWc130_assertion description "[We identified RIL, a LIM domain gene mapping to 5q31, a region frequently deleted in acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS), as methylated in 55 of 79 (70%) of cancer cell lines tested.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP798682.RAXHzD4PR82fpNM7XkhVbGRau0FPTJd9V6fNLCFv6QrWc130_provenance.
- NP848791.RASBHR-XXfiQ2MK7VhFF7DPkZaUXtpq5iUE-g6kvbEbYI130_assertion description "[We identified RIL, a LIM domain gene mapping to 5q31, a region frequently deleted in acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS), as methylated in 55 of 79 (70%) of cancer cell lines tested.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP848791.RASBHR-XXfiQ2MK7VhFF7DPkZaUXtpq5iUE-g6kvbEbYI130_provenance.
- assertion description "[We identified RIL, a LIM domain gene mapping to 5q31, a region frequently deleted in acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS), as methylated in 55 of 79 (70%) of cancer cell lines tested.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We identified RIL, a LIM domain gene mapping to 5q31, a region frequently deleted in acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS), as methylated in 55 of 79 (70%) of cancer cell lines tested.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP818898.RAPjsAmAvQYTJBlzyG7HBfdCDNtDjdV076vpMytaapDOM130_assertion description "[We identified RIL, a LIM domain gene mapping to 5q31, a region frequently deleted in acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS), as methylated in 55 of 79 (70%) of cancer cell lines tested.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP818898.RAPjsAmAvQYTJBlzyG7HBfdCDNtDjdV076vpMytaapDOM130_provenance.
- NP848657.RAqH7x_UPQUvzMpGA4oiNuB8FmMk7VvbpudBFPq9YgA4U130_assertion description "[We identified RIL, a LIM domain gene mapping to 5q31, a region frequently deleted in acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS), as methylated in 55 of 79 (70%) of cancer cell lines tested.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP848657.RAqH7x_UPQUvzMpGA4oiNuB8FmMk7VvbpudBFPq9YgA4U130_provenance.
- NP596658.RAIFgx6Iz5hWUJjWDzD9yNDG24_Wp-UgGf3l8XzPKdff4130_assertion description "[We identified RIL, a LIM domain gene mapping to 5q31, a region frequently deleted in acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS), as methylated in 55 of 79 (70%) of cancer cell lines tested.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP596658.RAIFgx6Iz5hWUJjWDzD9yNDG24_Wp-UgGf3l8XzPKdff4130_provenance.
- NP848690.RAM5pc7YJHkVUyuFmSYd4Gk_xhLnsHL_fRYhiFYG6HlR4130_assertion description "[We identified RIL, a LIM domain gene mapping to 5q31, a region frequently deleted in acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS), as methylated in 55 of 79 (70%) of cancer cell lines tested.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP848690.RAM5pc7YJHkVUyuFmSYd4Gk_xhLnsHL_fRYhiFYG6HlR4130_provenance.
- NP848702.RAL4KdqsORevdugK4WjydxqERmiF97GmVJobwychSNEzg130_assertion description "[We identified RIL, a LIM domain gene mapping to 5q31, a region frequently deleted in acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS), as methylated in 55 of 79 (70%) of cancer cell lines tested.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP848702.RAL4KdqsORevdugK4WjydxqERmiF97GmVJobwychSNEzg130_provenance.